Human α 1 -acid glycoprotein (AGP) is an abundant human plasma glycoprotein that may be N-glycosylated at five positions. AGP plays important roles on pharmacokinetics and can rise up to 5-fold in inflammatory events. In such events, the glycan chains attached to Asn54, Asn75 and Asn85 may become fucosylated, originating a sialyl-Lewis X epitope. This epitope, in turn, can bind selectin proteins. Such interplay is important for immunomodulation. While the X-ray structure of unglycosylated AGP has been reported, the absence of the glycan chains hampered the further insights into its structural biology and, ultimately, into its biological function. Thus, the current work intends to contribute in the characterization of the structural glycobiology and function of AGP by building a structural model of its fully glycosylated form, taking into account the different glycoforms that are found in vivo. The obtained data points to the absence of a major influence of glycosylation on AGP's secondary structure, in agreement with crystallography observations. However, the glycan chains seem able to interfere with the protein dynamics, mainly at the AGP-ligand-binding site, indicating a possible role in its complexation to drugs and other bioactive compounds. By examining the influence of fucosylation on AGP structure and binding to selectins, it is proposed that the latter may bind to glycan chains linked to Asn54 and Asn75, and that this binding may involve other glycans, such as the one attached to Asn15. These results point to an increased participation of carbohydrates on the observed AGP roles in pharmacokinetics and inflammation.
Introduction
The α-1 acid glycoprotein (AGP), or orosomucoid, is an abundant human plasma glycoprotein. Despite being known since 1950 (Schmid 1950 (Schmid , 1953 , its biological role is still unclear. Several potential physiological activities were described for this protein, such as drug-binding functions (Wasan et al. 2008) , inflammatory and immunomodulatory effects (Fournier et al. 2000) . The AGP is mainly secreted by hepatocytes, and its expression is regulated by several pro-inflammatory cytokines. An important aspect of AGP is that its concentration may rise up to 5-fold in inflammatory events, making this protein one of the major members of the acute-phase protein family (Fournier et al. 2000) .
AGP has a lipocalin fold (Schönfeld et al. 2008 ) with an extraordinary N-linked carbohydrate content (ca. 45%, w/w), considered to be one of the most glycosylated known proteins (Fournier et al. 2000) . These glycan chains are attached to asparagine residues at positions 15, 38, 54, 75 and 85, with variable carbohydrate compositions and degrees of branching (Fournier et al. 2000) . Some studies have tried to cross distinct experimental data to pinpoint specific glycosylation structures to each modified Asn residue (Sei et al. 2002; Nagy et al. 2004; Nakano et al. 2004) . Such variation on AGP carbohydrate moieties has been associated to distinct physiological and cellular events (Fournier et al. 2000) . In chronic inflammatory conditions like septic shock (Brinkman-van der Linden et al. 1996) and rheumatoid arthritis (Olewicz-Gawlik et al. 2007) , the degree of branching and fucosylation increases in proportion to the disorder severity in glycan chains attached to Asn54, Asn75 and Asn85. As a result, the sialyl-Lewis X epitope, or SLe x (α-NeuAc-(2 → 3)-β-Gal-(1 → 4)-(α-Fuc-(1 → 3))β-GlcNAc) is formed. The presence of this epitope suggests the participation of AGP in several physiological events (Graaf et al. 1993; Brinkman-van der Linden et al. 1996; Levander et al. 2009 ). For example, SLe x is the binding epitope for the cell adhesion molecules E-and P-selectins, involved in the inflammatory-dependent adhesion of neutrophils, monocytes, or platelets (Lasky 1992) . Moreover, in tumor metastasis, the increased expression of AGP with SLe x facilitates the binding of the latter to endothelial cells via selectins and these contribute to tumorcell migration towards distant tissues and metastasis promotion (Dube and Bertozzi 2005) . It is proposed that the increased fucosylation and the consequent biosynthesis of the SLe x epitope on AGP glycans may represent a mechanism for feedback inhibition of granulocyte extravasation in cases of inflammation (Fournier et al. 2000) . AGP and serum albumin are the two major responsible proteins for drug binding in humans. Understanding the binding mechanism of these proteins is therefore important for pharmacokinetics studies when proposing new drug candidates (Yasgar et al. 2012) . The physical-chemical properties of AGP favor binding with basic or neutral compounds of endogenous and exogenous origins, such as tamoxifen, propranolol, heparin, serotonin, platelet activating factor, melatonin, histamine and endogenous steroids (Fournier et al. 2000) . The AGP crystallographic structure has a pocket with a diameter of 9-12 Å with two positively charged residues, Arg68 and Arg90 (Schönfeld et al. 2008 ), but offers no information regarding glycan influence on the pocket, since it was obtained without glycosylations.
Thus, the current work intends to contribute in the characterization of the AGP structural glycobiology by including carbohydrate information on the protein structure and dynamics. The complete AGP glycosylation pattern was modeled at the atomic level, as well as some of its distinct glycoforms, such as the one containing the SLe x epitope.
Upon refinement of these models by molecular dynamics (MDs) simulations, the obtained data offer new insights into AGP role on inflammatory processes and interaction with P-selectin, as well as into its carbohydrates' role on AGP binding to drugs and other bioactive compounds.
Results and discussion

Carbohydrate dynamics
The glycan chains were built following a procedure previously described (Pol-Fachin et al. 2009; Fernandes et al. 2010) , including the use of the main conformational states of disaccharidic units as starting geometries, further refined through MD simulations (Figure 1) . Such proceeding was shown as able to properly reproduce the glycan chains' conformational space as determined by nuclear magnetic resonance techniques (Pol-Fachin et al. 2009; Fernandes et al. 2010 ). Using such approach, the AGP glycan chains were built attached to the protein moiety and the observed conformational behavior characterized through MD (Supplementary data, Figures S1-S4 ). These simulations presented a number of reversible transitions on most glycosidic linkage dihedral angles consistent with a converged simulation (Supplementary data, Figure S5 ). Additionally, the isolated glycan structures were also simulated and compared with results obtained for disaccharides (Supplementary data, . As a general feature, the glycosydic linkages on AGP populate the main conformational states of the respective disaccharidic units isolated in solution. In some cases, however, the minor conformational state of the isolated disaccharide or a conformation different from those found in disaccharides was the preferred conformation adopted in glycans attached to AGP.
Linkages in disagreement with disaccharide simulations were only 15 (11%), in a total of 136 (9 from the system without fucose and 6 from the system with fucose). For the glycans that were simulated in the absence of AGP, from 85 analyzed linkages, only 6 (7%) have shown disagreement with this data. The observed amount of disagreement between disaccharide and full glycan simulations is within the range found in previous method-validation works (Pol-Fachin et al. 2009; Fernandes et al. 2010 ). In our work, the disagreements were mainly with internal, branching residues, which were more restrained than their disaccharide equivalents.
In the system with fucose, the differences were mainly in the Asn85-attached glycan at linkages The other differences in the system with fucose were found in the glycan connected to Asn38, linkage β-GlcNAc-(1 → 4)-β-Man and Asn15-attached glycan, linkage NeuAc-(2 → 3)-β-Gal. These are the smallest glycans on the protein, and possibly the most rigid as well.
In the systems without fucose, the main differences between isolated disaccharides and AGP-linked glycan chains were found in a specific linkage, β-Gal-(1 → 4)-β-GlcNAc, at two branches of Asn15-and Asn85-linked glycans and in Asn54-and Asn75-attached carbohydrates. The β-GlcNAc-(1 → 4)-β-GlcNAc linkage presented differences in Asn15-and Asn54-linked glycans, as well as the α-Man-(1 → 3)-β-Man linkage in Asn54 glycan. These differences, mostly in β-1 → 4 linkages, have their main conformations located in regions of minor conformational states. According to previous works (Rao et al. 1998 ), GlcNAc β-1 → 4 linkages have two or three energy minima.
In general, the flexibility of the carbohydrates in the biantennary glycan linked to position 38 is reduced (Supplementary data, Figure S10 ) since less-branched glycans usually have lower flexibility than structures with increased branching (Woods et al. 1998) , such as the one attached to Asn75. Concerning the flexibility of the glycan during the simulation, only in Asn85 a different behavior was observed for the systems with and without fucoses (Supplementary data, Figure S10 ). The fucose system presented higher flexibility than the non-fucosylated system, with the SLe x epitope exposed to the protein surface moving to the core, and establishing interactions with the surrounding amino acids (see Structural implications for the potential participation of AGP on inflammatory processes for further details). When comparing protein-bound and unbound glycans, the general trend observed is that glycan chains attached to AGP reduce their exposure to solvent (while increasing the inter-residue hydrogen bonds). This differential solvent exposure is reflected in the glycan flexibility (Supplementary data, Figure S10 ). Major differences in solvent accessibility, as observed for the trees attached to Ans38 and their protein-unbound equivalent, are explained by the excess of solvent-derived hydrogen bonds for the latter case (in opposition to glycan/protein hydrogen bonds). For the fucosylated glycan structure attached to Asn85, which show the most variable solvent accessibility (larger deviation), the flexibility shown (calculated for the last 10 ns of The saccharides involved were GlcNAc, α/β-Man, Fuc, Gal and NeuAc. Snapshots of MD simulations for human AGP glycosylation structures (B) with fucoses and (C) without fucoses and (D) fit of final dynamics structures unglycosylated (green), with fucoses (red) and without fucoses (blue). For (B) and (C), snapshots were taken at every 20 ns and are shown only for the carbohydrate for clarity reasons, since the protein is much less flexible than the glycans and is shown in its initial conformation. This figure is available in black and white in print and in colour at Glycobiology online. simulation) somewhat masks the average flexibility of this glycan in comparison with the unbound counterpart.
The torsional angles adopted by the glycosidic linkages were similar for protein-bound and protein-unbound glycans (Supplementary data, Figures S2-S4 and S6-S9), with the exception of linkage βGlcNac(1 → 4)αMan (linkages "N" in Supplementary data, Figure S1 ). The difference observed for these linkages (unbound saccharide compared with the glycoprotein systems) is explained chiefly by differential hydrogen bonding. For this region of the saccharide, in the glycoprotein, there are 2.0 ± 1.3 hydrogen bonds formed with the glycans, 0.6 ± 0.7 with AGP, and 3.3 ± 1.4 with water molecules, while the isolated equivalent establishes 1.0 ± 1.1 bonds with the glycan, and 7.0 ± 1.9 with water molecules. Such difference renders this region slightly less solvent accessible (2.4 ± 0.3 nm 2 ) than its protein-bound counterpart (2.5 ± 0.2 nm 2 ). The hydrogen-bonding pattern differences allow the adoption of a distinguished torsional angle for this specific linkage. In addition to the previous measures, the torsional angles of linkages between Asn residues and the glycan structures (βGlcNac (1 → N)Asn) were inspected for all glycosylation sites and compared with their initial, system setup values. These simulation-derived angles were shown to be compatible with the initial structures (Supplementary data, Table S2 ). Furthermore, all linkages showed rotamer distributions within those observed previously by Petrescu et al. (2004) , in a survey of the entire Protein Data Bank for N-glycosylation sites.
Glycan chain role on protein moiety dynamics
The MD simulation of AGP in both glycosylated and non-glycosylated states supported the obtaining of insights into the influence of the carbohydrate residues on conformation and dynamics of the AGP peptidic segment. The obtained data indicate a lowering in the amino acids flexibility upon glycosylation of AGP (Figure 2) . Such effect appears to occur mainly at turns and coils (Figure 2A ), whereas some minor influence was also observed on the protein secondary structure ( Figure 2B ). Little change in secondary structure was observed after 150 ns of simulation for all systems (Supplementary data, Figure S11 ). While such influence of glycan chains on glycoproteins was observed in previous works (Woods et al. 1998; Pol-Fachin et al. 2009; Fernandes et al. 2010) , it was also suggested for AGP based on circular dichroism (Ceciliani and Pocacqua 2007) .
At the residue level, the root mean square fluctuation (RMSF) analysis demonstrates a region with a major flexibility in the unglycosylated system, around residue 150 ( Figure 2C ). This region corresponds to a long loop between two helices in the C-terminus, at the surface of the protein. In the glycosylated systems, this region was no longer exposed to the surrounding solvent and the glycan trees seem to obstruct the loop movements, decreasing its flexibility. Regarding the two glycosylated simulations, both show a similar behavior at the residue level.
Drug-binding site dynamics
AGP and albumin are the most important drug carriers in plasma (Trainor 2007) , with the difference that albumin favors acid molecules while AGP binds preferentially basic and neutral molecules, such as warfarin (Otagiri et al. 1987 ) and imatinib (Fitos et al. 2006 ). This preference may be related to the presence of neuraminic acid residues in the surface of the glycoprotein, since the glycan chains can take part in expanding the cavity size (see ahead). Thus, AGP is an important glycoprotein in studies of pharmacokinetics and efficacy of many therapeutic compounds and consequently in the improvement of drug design models (Parikh et al. 2000; Trainor 2007; Watanabe et al. 2013) . The glycan portion of AGP is essential for immunomodulatory effects and may take part in ligand binding (Fournier et al. 2000) . The latter has been investigated in previous docking studies with diazepam and progesterone, aimed to understand their transport (Schönfeld et al. 2008) . These studies however did not include the glycan portion of the glycoprotein. While in our simulations the AGP cavity was empty, the influence of glycosylation on the recognition of AGP ligands was explored through analysis of the cavity dynamics. For comparison, volumes of diazepam and progesterone were measured in UCSF Chimera program (Pettersen et al. 2004) , yielding 245.8 and 307.4 Å 3 , respectively. Initially, all cavities had a volume similar to the crystallographic structure, ∼750 Å 3 (not considering the influence of carbohydrate moieties on expanding the cavities). This volume is somewhat kept constant during the progress of the simulations. On the other hand, the simulations of the entire glycoprotein show that carbohydrate moieties are able to expand the original cavity, by providing additional scaffolds for molecular binding (Figure 3 ) acting as a border surrounding the central cavity. The observed cavity volumes would allow broad fit for drugs carried by AGP, based solely on volume (Schönfeld et al. 2008) . None of these phenomena were observed to be influenced by fucosylation of AGP. It has been shown recently that desialylation of AGP diminishes its ability of binding to progesterone and propranolol (Huang and Hudgens 2013) , further highlighting the importance of different glycosyl structures for controlled ligand binding in complex inflammatory events.
Structural implications for the potential participation of AGP on inflammatory processes
Selectins are glycoprotein lectins with anti-inflammatory properties, present in acute inflammation phase (Alencar et al. 2009 ). This class of molecules include P-selectin, responsible for the recognition of the SLe x epitope. The AGP binding to P-selectin blocks its binding to leukocytes, which may modulate extravasation into inflamed tissues (Fournier et al. 2000) . The structure of P-selectin was solved attached to SLe x (Somers et al. 2000) , revealing the ligand conformation required by the lectin (PDB ID 1G1S). This binding also requires the presence of calcium ion, hexacoordinated to P-selectin and SLe x fucose residue. Additionally, the SLe x bioactive conformation includes φ = −75°and ψ = −100°associated to α-Fuc-(1 → 3)-β-GlcNAc, φ = −70°o r −80°and ψ = 140°associated to β-Gal-(1 → 4)-β-GlcNAc and φ = 60°and ψ = −110°or −120°to α-NeuAc-(2 → 3)-β-Gal (Figure 4 ). Small variations in some angles were observed depending on the SLe x molecule measured in the crystal.
In order to observe the binding of P-selectin to AGP, the choice of SLe x in the same orientation as found in the crystallographic molecule aided in the process of conformational selection (Vaidehi & Kenakin 2010) . This approach took advantage of the functional selectivity of P-selectin binding to SLe x from the AGP glycan (Somers et al. 2000) . Thus, SLe x conformations similar to those found in the crystallographic structure were searched on the unbound glycosylated AGP, offering some bioactive conformations that were pre-existing in solution for all glycan positions, except for the glycan attached to Asn85. In this case, the disaccharide angles differ in the majority of simulation frames (Figure 4 ), hiding SLe x towards AGP surface (about three hydrogen bonds are formed between AGP and SLe x during the simulation) and thus hampering its binding to P-selectin. Taking this observation into account, the SLe x present in the glycan chains attached to positions Asn54 and Asn75, in the expected bioactive conformations, were selected from simulations and docked to P-selectin in presence of the calcium ion. Both positions were compatible with the expected metal coordination, including orientations towards fucose and P-selectin ( Figure 5 ). These complexes were further submitted to MD simulations in order to refine them in the presence of explicit solvent. The simulations of P-selectin containing SLe x complexed to AGP indicated a good reproduction of the crystallographic information for glycans bound to Asn54 and Asn75 ( Figure 5 ). In the case of Asn85, the φ angle of β-Gal-(1 → 4)-β-GlcNAc linkages and the φ and ψ angles of α-NeuAc-(2 → 3)-β-Gal show some deviation from crystallographic information (Figure 4) , reinforcing the specific conformation of the glycan attached to this position. Still, both glycans attached to Asn54 and Asn75 presented interactions with P-selectin. The simulation of the complexed proteins was also carried out in the absence of Ca 2+ ions. The overall behavior of the glycan rotamer distributions was similar in both cases (Supplementary data, Figures S12-S19). The ω rotamer was set in the gt conformation for the initial simulation structures in all cases, based on its prevalence in solution. This rotamer, however, populated both gt and gg conformations in solution throughout the multiple simulations, and very rarely adopted the tg conformation. The conformational variety of this rotamer in the simulations therefore did not biased the simulation outcomes. The adequate sampling of broad conformational spaces with this glycan building method has been demonstrated previously (Pol-Fachin and Verli 2011) . Regarding the interactions between AGP and P-selectin in the presence of calcium, in the case of Asn54-linked glycan the interaction with P-selectin involves 7.9 ± 2.6 hydrogen bonds per frame, from which 4.7 ± 1.6 interactions are due to the SLe x portion. For the Asn75-bound glycan, the complex with P-selectin includes 6.4 ± 2.9 hydrogen bond interactions, being 2.1 ± 1.6 specifically with the SLe x portion. These values were similar to those observed for the systems without calcium, which were of 5.3 ± 2.6 hydrogen bonds per frame for the Asn54-linked glycan interaction with P-selectin (4.5 ± 2.5 due to the SLe x portion), and of 8.9 ± 2.5 for the Asn75-bound glycan (5.9 ± 1.6 due to the SLe x portion). Interaction energy evaluation results were also very similar for these systems (data not shown). For the timescale explored in the current work, there seems to be little difference between calcium-free and calcium-bound systems.
Conclusions
In this work, we were able to obtain models of AGP in two glycosylated forms employing its crystallographic structure and the sequences of glycosylation of the five glycosylation sites obtained from mass spectroscopy. The protein dynamics demonstrated major flexibility of the unglycosylated structure when compared with its glycosylated forms, pointing to a glycosylation-induced stabilization of the protein.
Glycosylation has been shown to decrease protein flexibility in MDs studies. Nonetheless, non-computational biochemical studies on different proteins have shown the same results for hemagglutinin, fibronectin and IgM (Wormald et al. 1991; O'Connor and Imperiali 1998; Perodnet et al. 2004 ) while N-glycosylation itself is considered a mechanism for structural stabilization in folding proteins (Helenius and Aebi 2004) . Besides the stabilization of the protein, the different glycosylation forms do not interfere with the flexibility of the glycans, and the main influence of glycosylation seems to be related to AGP cavity preservation. The binding of AGP to P-selectin was shown to be possible through glycans attached to positions Asn54 and Asn75, while Asn85-linked glycan was not able to dock to P-selectin due to the SLe x orientation towards the core of AGP. This involved a series of interactions that promote glycosidic linkage geometry modifications that distance them from the bioactive one described in the crystallographic structure. Finally, these complexes were further refined through MD simulations, maintaining the crystallographic distances for P-selectin and SLe x (Somers et al. 2000) , with this interaction depending on fucose and calcium ion. Considering the overwhelming variation observed for AGP glycoforms, it is interesting to point out the importance of the glycan structures surrounding the SLe x -containing tree, since these "non-binding" glycans seem to take part in the complex scenario of AGP-P-selectin interaction, as observed in the present work.
Computational methods
Glycan nomenclature
The IUPAC nomenclature recommendations and symbols (IUPAC-IUB 1996) is followed in the description of glycans in this work. The relative orientation of a pair of contiguous carbohydrate residues was described for different types of linkages, by two or three torsional angles at the glycosidic linkage. A (1 → X) linkage, where "X" is "2", "3", "4" or "6", respectively. The φ and ψ angles were defined as shown below (in the α-D-neuraminic acid, NeuAc, case the linkage was (2 → X) and X would be "3" or "6"):
For a (1 → 6) linkage, the ω angle was defined as follows:
Construction of glycan chains
Carbohydrate trees building and modeling The human AGP crystallographic structure was retrieved from Protein Data Bank (PDB) under ID 3KQ0 (Schönfeld et al. 2008 ). The five glycans that are linked to AGP (at Asn15, Asn38, Asn54, Asn75 and Asn85) were selected according to previous works (Sei et al. 2002; Nagy et al. 2004; Nakano et al. 2004) . These works create a set of limitations on which glycosylation trees can be attached to each site of AGP, based on various experimental evidences (including prevalence in different physiological states). In view of the vast array of putative trees that can be proposed [up to 10 5 theoretical trees (Fournier et al. 2000) ], for the present work the most parsimonious trees were employed. Additionally, considering the absence of information regarding linkage prevalence for neuraminic acid for these trees (since the analytical method employed did not detect or discriminate it), the αNeuAc-(2 → 3)-βGal linkage was chosen because this is the linkage present in SLe x (Graaf et al. 1993) . The glycan trees attached to Gal) and NeuAc ( Figure 1A) . In order to understand the effect of fucosylation on the AGP glycan structure, three systems were constructed, one with AGP without glycosylation, one with the glycosylation described in Figure 1A , and one with a glycosylation equivalent to the latter but without the three fucose residues of glycans Asn54, Asn75 and Asn85. The saccharide structures were built following previous protocols (Pol-Fachin et al. 2009; Fernandes et al. 2010) . Briefly, all composing dissacharides had their glycosydic bonds evaluated, having their energy minima conformations selected as reference to build the entire glycosylation structures. All disaccharides that compose glycan trees were simulated in a previous work (Fernandes et al. 2010 ) and the topology and charge information were added to the Gromos 43a1 force field (Van Der Spoel et al. 2005) according to previous results (Verli and Guimarães 2004; Becker et al. 2005) . For additional comparisons, the six glycan trees were also simulated in solution in their isolate forms (not bound to the protein).
Glycoprotein modeling
The glycoprotein structures were constructed in the Glycoscience portal (Lutteke et al. 2004 ) using the GlyProt modeling tool. These initial 3D models had their glycosidic linkage geometries adjusted to the respective disaccharide major conformational state in solution, obtained from MD simulations, as previously reported (Pol-Fachin et al. 2009; Fernandes et al. 2010) to build an initial model for MD simulations.
AGP-P-selectin complex
The AGP-P-selectin complex was built employing the AGP-derived model, as described in the Carbohydrate trees building and modeling section, and the crystallographic structure of P-selectin complexed with SLe x under PDB ID 1G1S (Somers et al. 2000) . The dihedral angles of the glycosidic linkage, as described in this crystallographic complex, were used as reference to search within the fucosylated AGP simulation all SLe x epitope conformational states that would Fig. 5 . Representation of AGP-P-selectin complex formed in presence of calcium (blue). P-selectin was linked to Asn54-bound glycan (green) and Asn75-bound glycan (brown). The AGP proteins in both complexes were fit and the other glycan trees not involved in the initial interactions were hidden to facilitate visualization of the complexes. This figure is available in black and white in print and in colour at Glycobiology online.
be suitable to bind P-selectin (based on the absence of steric hindrance or volumetric superimposition of the proteins). The fucosylated AGP models that satisfied this condition were chosen to be employed in rigid docking with P-selectin.
MDs simulations
AGP molecular dynamics
The characterization of AGP structural glycobiology employed MD simulations of three molecular systems: (i) unglycosylated AGP, (ii) fucosylated AGP and (iii) glycosylated, non-fucosylated AGP. The two glycosylation forms were identical except for the three fucoses that form the SLe x in the Asn54, Asn75 and Asn85 glycosylation positions ( Figure 1A ). These systems were analyzed taking the crystal structure (Schönfeld et al. 2008) as reference, along with the disaccharide linkages conformational ensemble in solution (Fernandes et al. 2010) , in order to characterize the mutual influence between carbohydrate and protein moieties. The three systems went through MD simulations under explicit aqueous solution using the GROMACS simulation suite (Van Der Spoel et al. 2005) . The protein and glycoproteins were solvated in triclinic boxes using periodic boundary conditions and the SPC water model (Berendsen et al. 1987) . The Lincs method (Hess et al. 1997) was applied to constrain covalent bond lengths, allowing an integration step of 2 fs after an initial energy minimization using Steepest Descents algorithm. Electrostatic interactions were calculated using the Particle Mesh Ewald method (Darden et al. 1993 ). Temperature and pressure were kept constant by coupling disaccharides, ions and solvent to external temperature and pressure baths, with coupling constants of τ = 0.1 and 0.5 ps (Berendsen et al. 1984) , respectively, and the reference temperature was adjusted to 310 K. The systems were slowly heated from 50 to 310 K, in steps of 5 ps, each one increasing the reference temperature by 50 K. Each simulation was extended to 0.15 µs.
Based on previous studies (Pol-Fachin et al. 2009; Fernandes et al. 2010) , the oligosaccharides were analyzed by their disaccharide moieties, and the major conformational population of φ and ψ angles of these pairs were used to refine the initial structure of glycosylation.
Cavities measurement
The drug-binding cavity of AGP was measured during the simulations using the trj_cavity program (version 1.1) (Paramo et al. 2014) . The full length of simulation was evaluated with this tool, using default settings. As a reference, two drugs that bind to AGP had their volume measured with the UCSF Chimera program (version 1.4.1) (Pettersen et al. 2004 ).
Supplementary material
Supplementary Material is available at http://glycob.oxfordjournals. org/ online.
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